Vicarious Surgical Inc. (RBOT)
| Market Cap | 530.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 17.74M |
| Shares Out | 121.72M |
| EPS (ttm) | 0.15 |
| PE Ratio | 29.07 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 78,276 |
| Open | 4.56 |
| Previous Close | 4.59 |
| Day's Range | 4.32 - 4.60 |
| 52-Week Range | 2.82 - 15.79 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 9.95 (+128.2%) |
| Earnings Date | Aug 8, 2022 |
About RBOT
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for RBOT stock is "Buy." The 12-month stock price forecast is 9.95, which is an increase of 128.21% from the latest price.
News
Vicarious Surgical to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical Reports Second Quarter 2022 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Present at the Canaccord Genuity 42nd Annual Growth Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Report Second Quarter 2022 Financial Results on August 8, 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and ou...
Vicarious Surgical Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Present at the Cowen 7th Annual FutureHealth Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical Reports First Quarter 2022 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Report First Quarter 2022 Financial Results on May 9, 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and ou...
Vicarious Surgical Announces Cleanroom Qualification for Manufacturing of the Vicarious System
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical pr...
Vicarious Surgical Appoints John Mazzola as Vice President of Operations
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Analysts Move To Sidelines On Vicarious Surgical After Regulatory Update
Piper Sandler has downgraded Vicarious Surgical Inc (NASDAQ: RBOT) to Neutral from Overweight with a price target of $7, down from $16, below expected Q4 results. A majority of the earnings call focuse...
Vicarious Surgical Reports Fourth Quarter and Full Year 2021 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious to Participate in Upcoming Investor Conferences
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Report Fourth Quarter 2021 Financial Results on March 3, 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical Receives Three Built In Boston's 2022 Best Places to Work Awards
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical is proud to announce it has been honored with three awards from Built In's 2022 Best Places To Work Awards. Specifically, Vicarious Surgical earned a ...
Vicarious Surgical Wins MedTech Powerhouse Company of the Year at New England Venture Capital Association's 2021 NEVY...
BOSTON--(BUSINESS WIRE)--Vicarious Surgical (NYSE: RBOT, RBOT WS) announces it has won the MedTech Powerhouse Company of the Year Award at the 2021 NEVY Awards, hosted by the New England Venture Capital...
Vicarious Surgical to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical Reports Third Quarter 2021 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Present at the Credit Suisse 30th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical to Report Third Quarter 2021 Financial Results on November 8, 2021
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
Vicarious Surgical Enters Long-Term Lease, Expanding Footprint for Continued Growth
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes ...
SPAC Watch: Will This Be the Next Intuitive Surgical?
Robotic surgery is on fire as a new Intuitive Surgical competitor is about to come public via a SPAC merger.